Peter Frampton on His Diagnosis of Myositis; Ethical Perspectives on Costly Drugs and Healthcare
Release Date: 10/04/2021
Peripheral Neuropathy and Prolonged COVID
Neurology® Podcast
Dr. Derek Stitt talks with Dr. Anne Oaklander about the association of long COVID with incident polyneuropathy affecting the small-fiber axons. Read the .
info_outline
Cardiac Arrhythmia in Patients with Drug-Resistant Epilepsy
Neurology® Podcast
Dr. Halley Alexander talks with Dr. Shóbi Sivathamboo about the incidence of serious cardiac arrhythmias detected by subcutaneous cardiac monitors in patients with chronic drug-resistant epilepsy. Read the .
info_outline
Neuromodulation Restores Function in Spinal Cord Injury
Neurology® Podcast
Dr. Jeff Ratliff talks with Dr. Andreas Rowald about the efficacy of activity-dependent spinal cord neuromodulation, which was shown to rapidly restore trunk and leg motor functions in patients with spinal cord injury after complete paralysis.
info_outline
Prognosis and Treatment of Spinal Cord Sarcoidosis
Neurology® Podcast
Dr. Stacey Clardy discusses the prognostic factors and efficacy of immunosuppressive treatments for spinal cord sarcoidosis with Dr. Antoine Gavoille. Read the .
info_outline
Cost Burden of MS in the US
Neurology® Podcast
Dr. Justin Abbatemarco talks with Dr. Bruce Bebo about the estimated economic burden of multiple sclerosis in the US, highlighting direct and indirect cost drivers. Read the . Please be sure to check out , which connects patients with MS and their family members to experts who can help them navigate the challenges of MS, from making workplace accommodation requests to case management assessment.
info_outline
May 2022 Neurology Recall: Autoimmune Neurologic Diseases of the CNS
Neurology® Podcast
The May 2022 replay of past episodes showcases a selection of interviews about autoimmune neurologic diseases of the central nervous system. This episode features illuminating conversations with Drs. Josep Dalmau, Jérôme Honnorat, and Carles Gaig on the clinical evaluation of first episode psychosis, GFAP autoimmune syndrome, and anti-IgLON5 disease, respectively, as well as a suite of clinical pearls for each syndrome. This month's Recall concludes with a useful series from Dr. Justin Abbatemarco on navigating instances when autoantibodies are not clearly correlated with a distinct...
info_outline
Brain Networks and Cognitive Decline in DBS for Parkinson Disease
Neurology® Podcast
Dr. Jeff Ratliff talks with Dr. Michael Fox about the association of connectivity between brain networks and sites of deep brain stimulation (DBS) with DBS-induced cognitive decline in patients with Parkinson disease. Check out the free clinical tool designed to help DBS programmers based on the research discussed in this episode .
info_outline
Sudden Death and Cardiac Arrhythmia with Lamotrigine
Neurology® Podcast
Dr. Halley Alexander talks with Dr. Mark Keezer about the risk of sudden death and cardiac arrhythmia in patients utilizing lamotrigine to treat epilepsy. Read the .
info_outline
Priorities from the 2022 ADRD Summit with Walter Koroshetz
Neurology® Podcast
Dr. Gregg Day talks with Dr. Walter Koroshetz, Director of NINDS, about research recommendations, priorities, and outcomes at the 2022 Alzheimer's Disease-Related Dementias (ADRD) Summit.
info_outline
Amyloid Treatments for Alzheimer Disease
Neurology® Podcast
Dr. Jason Crowell talks with Dr. Gregg Day about amyloid-targeting treatments for Alzheimer disease as well as how to navigate conversations about aducanumab with patients.
info_outlineIn the first part of the podcast, Dr. Ted Burns interviews legendary musician Peter Frampton about his experience with inclusion body myositis and his storied career. For more with Peter Frampton, read the cover story in the October/November 2020 issue of Brain & Life, the AAN’s patient and caregiver magazine. In the second segment, Dr. Gordon Smith talks with Dr. Amy Tsou about the updated AAN Position Statement on ethical concerns raised by high drug costs.